Carlton Highsmith - Paragon 28 Independent Director

FNA Stock  USD 10.53  0.76  7.78%   

Director

Carlton L. Highsmith is Independent Director of Company. He is Chairman of the GovernanceNominating Committee and a member of the Audit Committee. He was appointed to the Board in connection with our merger with New Alliance Bancshares Inc. where he served on the Compensation and Loan Committees of the Board since 2006. He founded The Specialized Packaging Group based in Hamden Connecticut in 1983 and served as its President and Chief Executive Officer from 1983 to 2009. He grew his company to become one of North Americas largest independent paperboard packaging manufacturers. He merged his company with PaperWorks Industries in 2009 to form the third largest integrated recycled paperboard manufacturing company in North America and assumed the role of Vice Chairman of the Board until his retirement in 2010 since 2011.
Age 63
Tenure 13 years
Address 14445 Grasslands Drive, Englewood, CO, United States, 80112
Phone855 786 2828
Webhttps://paragon28.com
Highsmith is a Trustee of Quinnipiac University, Chairman of Connecticut Center for Arts & Technology, a Director of Achievement First Charter School Management Organization, and Chairman of I Have a Dream, New Haven. He served on the Federal Reserve Bank of Boston Community Development Advisory Council of New England and is a member of the Yale New Haven Hospital Board of Trustees, where he serves on the Finance and Budget Committee. He provides the Board with deep knowledge of the New England and Tristate business environment in which we operate as well as expertise in the areas of strategy and management that he gained in his career.

Paragon 28 Management Efficiency

The company has Return on Asset of (0.0784) % which means that on every $100 spent on assets, it lost $0.0784. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3003) %, meaning that it generated no profit with money invested by stockholders. Paragon 28's management efficiency ratios could be used to measure how well Paragon 28 manages its routine affairs as well as how well it operates its assets and liabilities. As of May 4, 2024, Return On Tangible Assets is expected to decline to -0.17. The current year's Return On Capital Employed is expected to grow to -0.12. At present, Paragon 28's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.34, whereas Total Assets are forecasted to decline to about 220.3 M.
The company has 112.03 M in debt with debt to equity (D/E) ratio of 0.24, which may show that the company is not taking advantage of profits from borrowing. Paragon 28 has a current ratio of 3.59, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Paragon 28 until it has trouble settling it off, either with new capital or with free cash flow. So, Paragon 28's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Paragon 28 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Paragon to invest in growth at high rates of return. When we think about Paragon 28's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Donald BerwickNational Research Corp
71
William SteadHealthStream
69
Dale PolleyHealthStream
67
JoAnn MartinNational Research Corp
63
Martin HarrisHealthStream
61
John NunnellyNational Research Corp
65
Thompson DentHealthStream
68
Jeffrey McLarenHealthStream
51
Harald ArnetNational Research Corp
N/A
Brita EilertsenNational Research Corp
53
Savita AcharyaNational Research Corp
41
Deborah TateHealthStream
61
Michael ShmerlingHealthStream
62
P ShastriNational Research Corp
65
Kjersti KanneNational Research Corp
N/A
Barbara MowryNational Research Corp
70
Linda RebrovickHealthStream
62
Martiny HarrisHealthStream
59
Frank GordonHealthStream
55
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. Paragon 28 operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 343 people. Paragon 28 (FNA) is traded on New York Stock Exchange in USA. It is located in 14445 Grasslands Drive, Englewood, CO, United States, 80112 and employs 574 people. Paragon 28 is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Paragon 28 Leadership Team

Elected by the shareholders, the Paragon 28's board of directors comprises two types of representatives: Paragon 28 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paragon. The board's role is to monitor Paragon 28's management team and ensure that shareholders' interests are well served. Paragon 28's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paragon 28's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Jarboe, Chief Officer
George Philip, Independent Director
Albert DaCosta, President, Chief Executive Officer, Co-Founder
B Johnson, Director
Kristina Wright, Independent Director
Matt Jarboe, Chief Commercial Officer
Matt Brinckman, Senior Relations
Carl Florio, Independent Director
Thomas Bowers, Independent Director
Gregory Norwood, CFO, Senior Vice President
RICHARD BARRY, Executive Vice President Chief Risk Officer
Austin Adams, Independent Director
Peter Robinson, Independent Director
Frank Bono, Co-Founder, Chief Technology Officer
Inder Koul, Executive Vice President CIO
LIAM BRICKLEY, Senior Vice President Chief Credit Officer
Jim Riegler, Co-Founder, Chief Financial Officer
Jeff Sears, Vice Operations
Erik Mickelson, Chief Controller
Krissy Wright, Director
Michelle Missal, VP Officer
Nathaniel Woodson, Independent Director
Susan Harnett, Director
Brandon Kraatz, IR Contact Officer
Julie Signorille, Executive Vice President Managing Director - Operations
Carlton Highsmith, Independent Director
Roxanne Coady, Independent Director
Brendan Shook, Executive Vice President - Marketing and Medical Education
Stephen Deitsch, Chief Officer
Steve Deitsch, Principal Financial Officer
Brian Dempsey, Chief Accounting Officer, Interim Corporate Controller, Director - Finance Accounting
Francis Bono, Co-Founder, Chief Technology Officer
John Shumaker, Executive US
Hans Kestler, Executive International
Kate White, Executive Vice President Managing Director - Human Resources and Corporate Communications
Gary Crosby, President CEO, Director
Lee Rosenthal, Co-Founder, Vice President - National Accounts
Andrew Hill, Executive Development
Jonathan Friedman, General Secretary
Jason Edie, Chief Officer
Joseph Saffire, Executive Vice President - Commercial Lending Services
Robert JD, General Secretary
Mark Rendulic, Executive Vice President - Retail Banking
Meghan Scanlon, Director

Paragon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Paragon 28 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Paragon 28 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Paragon 28's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Paragon 28 Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Paragon 28 Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Paragon 28. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Paragon Stock refer to our How to Trade Paragon Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Paragon Stock analysis

When running Paragon 28's price analysis, check to measure Paragon 28's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paragon 28 is operating at the current time. Most of Paragon 28's value examination focuses on studying past and present price action to predict the probability of Paragon 28's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paragon 28's price. Additionally, you may evaluate how the addition of Paragon 28 to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Paragon 28's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Paragon 28. If investors know Paragon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Paragon 28 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.58)
Revenue Per Share
2.636
Quarterly Revenue Growth
0.176
Return On Assets
(0.08)
Return On Equity
(0.30)
The market value of Paragon 28 is measured differently than its book value, which is the value of Paragon that is recorded on the company's balance sheet. Investors also form their own opinion of Paragon 28's value that differs from its market value or its book value, called intrinsic value, which is Paragon 28's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Paragon 28's market value can be influenced by many factors that don't directly affect Paragon 28's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Paragon 28's value and its price as these two are different measures arrived at by different means. Investors typically determine if Paragon 28 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Paragon 28's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.